Literature DB >> 28408291

Altered expression of circadian rhythm and extracellular matrix genes in the medial prefrontal cortex of a valproic acid rat model of autism.

Nikkie F M Olde Loohuis1, Gerard J M Martens2, Hans van Bokhoven1, Barry B Kaplan3, Judith R Homberg1, Armaz Aschrafi4.   

Abstract

Autism spectrum disorders (ASD) are a highly heterogeneous group of neurodevelopmental disorders caused by complex interplay between various genes and environmental factors during embryonic development. Changes at the molecular, cellular and neuroanatomical levels are especially evident in the medial prefrontal cortex (mPFC) of ASD patients and are particularly contributing to social impairments. In the present study we tested the hypothesis that altered neuronal development and plasticity, as seen in the mPFC of ASD individuals, may result from aberrant expression of functionally connected genes. Towards this end, we combined transcriptome sequencing and computational gene ontology analysis to identify the molecular networks impaired in the mPFC of a valproic acid (VPA) rat model of autism. This investigation identified two subsets of genes differentially expressed in the mPFC of VPA rats: one group of genes being functionally involved in the regulation of the circadian rhythm, while the second group encompasses a set of differentially expressed collagen genes acting within the extracellular matrix. Ultimately, our integrated transcriptome analysis identified a distinct subset of altered gene networks in the mPFC of VPA rats, contributing to our understanding of autism at the molecular level, thus providing novel insight into the genetic alterations associated with this neurodevelopmental disorder. Published by Elsevier Inc.

Entities:  

Keywords:  Animal model of autism; Collagen; Gene ontology analysis; Period circadian clock; Transcriptome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28408291      PMCID: PMC5502527          DOI: 10.1016/j.pnpbp.2017.04.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  47 in total

1.  Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism.

Authors:  I Nir; D Meir; N Zilber; H Knobler; J Hadjez; Y Lerner
Journal:  J Autism Dev Disord       Date:  1995-12

Review 2.  The study of autism as a distributed disorder.

Authors:  Ralph-Axel Müller
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

3.  Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories.

Authors:  Li Sui; Meng Chen
Journal:  Brain Res Bull       Date:  2012-02-06       Impact factor: 4.077

4.  Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder.

Authors:  M E Bringas; F N Carvajal-Flores; T A López-Ramírez; M Atzori; G Flores
Journal:  Neuroscience       Date:  2013-03-25       Impact factor: 3.590

5.  Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy.

Authors:  Luci Wiggs; Gregory Stores
Journal:  Dev Med Child Neurol       Date:  2004-06       Impact factor: 5.449

6.  Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism.

Authors:  Gilles Maussion; Jérôme Carayol; Aude-Marie Lepagnol-Bestel; Frédéric Tores; Yann Loe-Mie; Ulla Milbreta; Francis Rousseau; Karine Fontaine; Julie Renaud; Jean-Marie Moalic; Anne Philippi; Alain Chedotal; Philip Gorwood; Nicolas Ramoz; Jörg Hager; Michel Simonneau
Journal:  Hum Mol Genet       Date:  2008-05-20       Impact factor: 6.150

Review 7.  In utero exposure to valproic acid and autism--a current review of clinical and animal studies.

Authors:  Florence I Roullet; Jonathan K Y Lai; Jane A Foster
Journal:  Neurotoxicol Teratol       Date:  2013-02-08       Impact factor: 3.763

8.  Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum.

Authors:  Catherine Edmonson; Mark N Ziats; Owen M Rennert
Journal:  Mol Autism       Date:  2014-01-10       Impact factor: 7.509

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Late onset deficits in synaptic plasticity in the valproic acid rat model of autism.

Authors:  Henry G S Martin; Olivier J Manzoni
Journal:  Front Cell Neurosci       Date:  2014-01-31       Impact factor: 5.505

View more
  4 in total

Review 1.  Biological correlates of altered circadian rhythms, autonomic functions and sleep problems in autism spectrum disorder.

Authors:  Liliana Dell'Osso; Leonardo Massoni; Simone Battaglini; Ivan Mirko Cremone; Claudia Carmassi; Barbara Carpita
Journal:  Ann Gen Psychiatry       Date:  2022-05-09       Impact factor: 3.455

2.  Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice.

Authors:  Spencer M Moore; Jason S Seidman; Jacob Ellegood; Richard Gao; Alex Savchenko; Ty D Troutman; Yohei Abe; Josh Stender; Daehoon Lee; Sicong Wang; Bradley Voytek; Jason P Lerch; Hoonkyo Suh; Christopher K Glass; Alysson R Muotri
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

3.  Disrupted Social Hierarchy in Prenatally Valproate-Exposed Autistic-Like Rats.

Authors:  Péter Pelsőczi; Kristóf Kelemen; Cecília Csölle; Gábor Nagy; Balázs Lendvai; Viktor Román; György Lévay
Journal:  Front Behav Neurosci       Date:  2020-01-15       Impact factor: 3.558

Review 4.  Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Biomedicines       Date:  2022-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.